The predictive value of serum soluble ICAM-1 and CXCL13 in the therapeutic response to TNF inhibitor in rheumatoid arthritis patients who are refractory to csDMARDs

Zhao, J; Ye, X; Zhang, ZL

Zhang, ZL (corresponding author), Peking Univ First Hosp, Dept Rheumatol & Clin Immunol, Beijing 100034, Peoples R China.

CLINICAL RHEUMATOLOGY, 2020; 39 (9): 2573

Abstract

Background Tumor necrosis factor-alpha (TNF alpha) inhibitors (TNFi) have greatly improved the prognosis of RA and become the first therapeutic option......

Full Text Link